<DOC>
	<DOCNO>NCT01057459</DOCNO>
	<brief_summary>This research trial study deoxyribonucleic acid ( DNA ) analysis predict response antibody therapy patient follicular lymphoma treat clinical trial Cancer Leukemia Group B ( CALGB ) -50402 CALGB-50701 . Studying sample blood patient follicular lymphoma laboratory may help doctor predict well patient respond treatment .</brief_summary>
	<brief_title>DNA Analysis Predicting Response Antibody Therapy Patients With Follicular Lymphoma Treated Clinical Trials CALGB-50402 CALGB-50701</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : l. To test hypothesis killer immunoglobulin-like receptor ( KIR ) human leukocyte antigen ( HLA ) genotypes predict overall response ( partial response [ PR ] , complete response [ CR ] , unconfirmed complete response [ CRu ] ) within 12 month rituximab-containing monoclonal antibody combination follicular lymphoma patient treat CALGB protocols 50402 50701 . SECONDARY OBJECTIVES : I . To test hypothesis KIR HLA genotype associate survival outcome ( progression-free survival [ PFS ] overall survival [ OS ] ) follicular lymphoma patient treat rituximab-containing monoclonal antibody combination CALGB protocols 50402 50701 . OUTLINE : Genomic DNA extract previously collect blood sample KIR HLA genotyping polymorphism analysis .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Follicular</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Untreated follicular lymphoma Has receive rituximabcontaining monoclonal antibody therapy CALGB50402 CALGB50701 Patients previously provide informed consent allow correlative study genomic DNA</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Stage II Grade 1 Contiguous Follicular Lymphoma</keyword>
	<keyword>Stage II Grade 1 Non-Contiguous Follicular Lymphoma</keyword>
	<keyword>Stage II Grade 2 Contiguous Follicular Lymphoma</keyword>
	<keyword>Stage II Grade 2 Non-Contiguous Follicular Lymphoma</keyword>
	<keyword>Stage II Grade 3 Contiguous Follicular Lymphoma</keyword>
	<keyword>Stage II Grade 3 Non-Contiguous Follicular Lymphoma</keyword>
	<keyword>stage III grade 1 follicular lymphoma</keyword>
	<keyword>stage III grade 2 follicular lymphoma</keyword>
	<keyword>stage III grade 3 follicular lymphoma</keyword>
	<keyword>stage IV grade 1 follicular lymphoma</keyword>
	<keyword>stage IV grade 2 follicular lymphoma</keyword>
	<keyword>stage IV grade 3 follicular lymphoma</keyword>
</DOC>